Canbridge Pharmaceuticals Relocates Hong Kong Office to Dah Sing Financial Centre
Reuters
Jul 11
Canbridge Pharmaceuticals Relocates Hong Kong Office to Dah Sing Financial Centre
CANbridge Pharmaceuticals Inc. has announced a change in its principal place of business in Hong Kong. Effective July 11, 2025, the company will relocate to the 40th Floor of Dah Sing Financial Centre, located at No. 248 Queen's Road East, Wanchai, Hong Kong. The company's website will remain unchanged. The Board of Directors includes Dr. James Qun Xue as executive Director, among others.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canbridge Pharmaceuticals Inc. published the original content used to generate this news brief on July 11, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.